Cyclooxygenases in cancer: progress and perspective.

[1]  Jeanne Kowalski,et al.  Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer , 2004, Cancer Research.

[2]  M. Bertagnolli.  The potential of non‐steroidal anti‐inflammatory drugs (NSAIDs) for colorectal cancer prevention , 2003, Journal of surgical oncology.

[3]  P. Fara.  Erratum to: “Carl Linnaeus: pictures and propaganda” [Endeavour 27(1) 14–15] , 2003 .

[4]  J. Kleibeuker,et al.  Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas , 2003, The Lancet.

[5]  G. Semenza,et al.  Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. , 2003, Cancer research.

[6]  P. Ricchi,et al.  Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy , 2003, British Journal of Cancer.

[7]  G. Beck,et al.  A randomized trial of aspirin to prevent colorectal adenomas. , 2003, The New England journal of medicine.

[8]  Susan Halabi,et al.  A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. , 2003, The New England journal of medicine.

[9]  J. Mitchell,et al.  Cyclooxygenase-3 (COX-3): Filling in the gaps toward a COX continuum? , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  N. V. Chandrasekharan,et al.  COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  F. Marks,et al.  Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Cameron,et al.  Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. , 2002, American journal of clinical pathology.

[13]  J. Reis-Filho,et al.  Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. , 2002, Journal of clinical pathology.

[14]  A. Badawi,et al.  Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review). , 2002, International journal of oncology.

[15]  S. Fischer,et al.  Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development. , 2002, Cancer research.

[16]  Xueqin Song,et al.  Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells. , 2002, Journal of the National Cancer Institute.

[17]  S. Piantadosi,et al.  Primary chemoprevention of familial adenomatous polyposis with sulindac , 2002 .

[18]  P. Adegboyega,et al.  Regulation of COX-2 expression in human intestinal myofibroblasts: mechanisms of IL-1-mediated induction. , 2002, American journal of physiology. Cell physiology.

[19]  A. Sahin,et al.  Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. , 2002, Cancer research.

[20]  S. Prescott,et al.  Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer , 2002, Journal of cellular physiology.

[21]  A. Tarnawski,et al.  Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy , 2002, Nature Medicine.

[22]  Michael J Thun,et al.  Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. , 2002, Journal of the National Cancer Institute.

[23]  W. Hong,et al.  Expression of cyclooxygenase‐1 and cyclooxygenase‐2 in bronchial epithelium and nonsmall cell lung carcinoma , 2002, Cancer.

[24]  J. Minna,et al.  Sulindac Enhances Tumor Necrosis Factor-α-mediated Apoptosis of Lung Cancer Cell Lines by Inhibition of Nuclear Factor-κB , 2002 .

[25]  W. Isaacs,et al.  Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. , 2001, Cancer Research.

[26]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[27]  N. Horikoshi,et al.  Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase. , 2001, Cancer research.

[28]  E. Fosslien.  Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. , 2001, Annals of clinical and laboratory science.

[29]  P. Vaupel,et al.  Association between host tissue vascularity and the prognostically relevant tumor vascularity in human cervical cancer. , 2001, International journal of oncology.

[30]  C. Rüegg,et al.  NSAIDs inhibit αVβ3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis , 2001, Nature Medicine.

[31]  S. Narumiya,et al.  Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice , 2001, Nature Medicine.

[32]  A. Dannenberg,et al.  Cyclooxygenase-2 Expression in the Developing Human Kidney , 2001, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[33]  J. Lindsten,et al.  The Nobel Prize in Physiology or Medicine , 2001 .

[34]  J. Masferrer,et al.  Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon. , 2001, Scandinavian journal of gastroenterology.

[35]  M. Morohashi,et al.  Immunohistochemical expression of cyclooxygenase‐2 in skin cancers , 2001, Journal of cutaneous pathology.

[36]  Aubrey R. Morrison,et al.  The 3′-Untranslated Region of Murine Cyclooxygenase-2 Contains Multiple Regulatory Elements That Alter Message Stability and Translational Efficiency* , 2001, The Journal of Biological Chemistry.

[37]  F. Marks,et al.  Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. Hla,et al.  Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice* , 2001, The Journal of Biological Chemistry.

[39]  A. Blomqvist,et al.  Inflammatory response: Pathway across the blood–brain barrier , 2001, Nature.

[40]  E. Lander,et al.  Deletion of cytosolic phospholipase A2 suppresses ApcMin-induced tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. J. Chen,et al.  Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells. , 2001, Molecular pharmacology.

[42]  R. Gaynor,et al.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.

[43]  A. Burke,et al.  EXPRESSION OF CYCLOOXYGENASE-2 IN THE MACULA DENSA OF HUMAN KIDNEY IN HYPERTENSION, CONGESTIVE HEART FAILURE, AND DIABETIC NEPHROPATHY , 2001, Renal failure.

[44]  D. Alberts,et al.  Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[45]  K. Kinzler,et al.  Role of BAX in the apoptotic response to anticancer agents. , 2000, Science.

[46]  Takao Shimizu,et al.  Suppression of Intestinal Polyposis inApc Δ 716 Knockout Mice by an Additional Mutation in the Cytosolic Phospholipase A2Gene* , 2000, The Journal of Biological Chemistry.

[47]  R. Panettieri,et al.  p38 MAP kinase regulates IL-1β responses in cultured airway smooth muscle cells , 2000 .

[48]  Makoto Murakami,et al.  Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.

[49]  G. Zimmerman,et al.  Intracellular unesterified arachidonic acid signals apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  P. Unger,et al.  Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. , 2000, Urology.

[51]  P. Abel,et al.  Cytoplasmic induction and over‐expression of cyclooxygenase‐2 in human prostate cancer: implications for prevention and treatment , 2000, BJU international.

[52]  Y. Sugimoto,et al.  Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors. , 2000, Japanese journal of pharmacology.

[53]  H. Müller,et al.  Germline alterations in the cyclooxygenase‐2 gene are not associated with the development of extracolonic manifestations in a large Swiss familial adenomatous polyposis kindred , 2000, International journal of cancer.

[54]  R. Langenbach,et al.  Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. , 2000, Cancer research.

[55]  P. Unger,et al.  Immunohistochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the human fetal and adult male reproductive tracts. , 2000, The Journal of clinical endocrinology and metabolism.

[56]  T. Hla,et al.  Expression of cyclooxygenase‐2 in prostate carcinoma , 2000, Cancer.

[57]  G. Piazza,et al.  Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin. , 2000, Cancer research.

[58]  L. G. García Rodríguez,et al.  Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study. , 2000, Epidemiology.

[59]  Y. Shyr,et al.  Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. , 2000, The American journal of pathology.

[60]  N. Tanji,et al.  Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma; relationship to apoptosis and Bcl-2 protein expression. , 2000, Anticancer research.

[61]  A. Knox,et al.  TGF-β1 stimulates IL-8 release, COX-2 expression, and PGE2release in human airway smooth muscle cells , 2000 .

[62]  B. Levin,et al.  The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.

[63]  S. Dey,et al.  Host cyclooxygenase-2 modulates carcinoma growth. , 2000, The Journal of clinical investigation.

[64]  N. Greenberg,et al.  E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. , 2000, Cancer research.

[65]  A. Hsu,et al.  The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2* , 2000, The Journal of Biological Chemistry.

[66]  D. Alberts,et al.  Effect of subacute ibuprofen dosing on rectal mucosal prostaglandin E2 levels in healthy subjects with a history of resected polyps. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[67]  Derek W. Gilroy,et al.  New insights into the role of COX 2 in inflammation , 2000, Journal of Molecular Medicine.

[68]  C. Bonifer,et al.  Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. , 2000, The American journal of pathology.

[69]  J. Epstein,et al.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. , 1999, The American journal of pathology.

[70]  A. Kato,et al.  High expression of cyclooxygenase‐2 in macrophages of human colonic adenoma , 1999, International journal of cancer.

[71]  K. Kinzler,et al.  PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs , 1999, Cell.

[72]  H. Sato,et al.  Activation of matrix metalloproteinase‐2 in human breast cancer cells overexpressing cyclooxygenase‐1 or ‐2 , 1999, FEBS letters.

[73]  S. Narumiya,et al.  Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. , 1999, Cancer research.

[74]  G. Piazza,et al.  Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. , 1999, Biochemical pharmacology.

[75]  R. Langenbach,et al.  Cyclooxygenase‐deficient Mice: A Summary of Their Characteristics and Susceptibilities to Inflammation and Carcinogenesis , 1999, Annals of the New York Academy of Sciences.

[76]  J. Morrow,et al.  Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. , 1999, Cancer research.

[77]  J. Hanley,et al.  Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing , 1999, British Journal of Cancer.

[78]  D. Heitjan,et al.  Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis. , 1999, Urology.

[79]  V. Natarajan,et al.  [The Nobel Prize in physiology or medicine]. , 1998, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[80]  H. Niiro,et al.  MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. , 1998, Biochemical and biophysical research communications.

[81]  R. DuBois,et al.  Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.

[82]  R. DuBois,et al.  Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.

[83]  J. Masferrer,et al.  COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. , 1998, Carcinogenesis.

[84]  S. Hamilton,et al.  Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. , 1998, Cancer research.

[85]  D. Scollard,et al.  Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. , 1998, Journal of the National Cancer Institute.

[86]  J. Morrow,et al.  Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. , 1998, Cancer research.

[87]  T. Nakajima,et al.  Why is cyclooxygenase‐2 expressed in neuroendocrine cells of the human alimentary tract? , 1997, Pathology international.

[88]  S. Dey,et al.  Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient Mice , 1997, Cell.

[89]  A. Ristimäki,et al.  Tumorigenic Transformation of Immortalized ECV Endothelial Cells by Cyclooxygenase-1 Overexpression* , 1997, The Journal of Biological Chemistry.

[90]  C. Rock,et al.  Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. , 1997, Journal of the National Cancer Institute.

[91]  J. Brown,et al.  The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan. , 1997, Cancer research.

[92]  J. Lehmann,et al.  Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs* , 1997, The Journal of Biological Chemistry.

[93]  R. Kurumbail,et al.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1997, Nature.

[94]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[95]  J. Chow,et al.  Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2 , 1996, Nature Structural Biology.

[96]  R. DuBois,et al.  Elevated cyclooxygenase-2 levels in Min mouse adenomas. , 1996, Gastroenterology.

[97]  J. Johnston,et al.  Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II , 1995, Nature.

[98]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[99]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[100]  Hyung-Suk Kim,et al.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.

[101]  M. Kondo,et al.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.

[102]  D. Reed,et al.  Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[103]  D. Alberts,et al.  Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. , 1995, Cancer research.

[104]  S Jothy,et al.  Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. , 1995, Cancer research.

[105]  R. Kulmacz,et al.  Prostaglandin H synthase-1: evaluation of C-terminus function. , 1995, Archives of biochemistry and biophysics.

[106]  K. Skorecki,et al.  Assignment of the human prostaglandin-endoperoxide synthase 2 (PTGS2) gene to 1q25 by fluorescence in situ hybridization. , 1994, Genomics.

[107]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[108]  C. Ji,et al.  Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. , 1994, The Journal of biological chemistry.

[109]  J. Mancini,et al.  Mutation of serine‐516 in human prostaglandin G/H synthase‐2 to methionine or aspirin acetylation of this residue stimulates 15‐R‐HETE synthesis , 1994, FEBS letters.

[110]  J. Falgueyret,et al.  Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. , 1994, Molecular pharmacology.

[111]  P. Loll,et al.  The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1 , 1994, Nature.

[112]  C. Williams,et al.  Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis , 1993, The British journal of surgery.

[113]  J. Otto,et al.  N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. , 1993, The Journal of biological chemistry.

[114]  L. Tertoolen,et al.  Epidermal growth factor—induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products , 1993, Cell.

[115]  J. Manson,et al.  Low-dose aspirin and incidence of colorectal tumors in a randomized trial. , 1993, Journal of the National Cancer Institute.

[116]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[117]  David A Jones,et al.  Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. , 1993, The Journal of biological chemistry.

[118]  D. Dewitt,et al.  Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. , 1993, The Journal of biological chemistry.

[119]  M. Schindler,et al.  Subcellular localization of prostaglandin endoperoxide synthase-2 in murine 3T3 cells. , 1993, Archives of biochemistry and biophysics.

[120]  T. Hla,et al.  Human cyclooxygenase-2 cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[121]  V. Winn,et al.  cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[122]  V. Winn,et al.  A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. , 1991, The Journal of biological chemistry.

[123]  P. Vielh,et al.  Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.

[124]  G. FitzGerald,et al.  Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[125]  T. Tanabe,et al.  Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequence , 1988, FEBS letters.

[126]  P. Needleman,et al.  Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). , 1988, The Journal of biological chemistry.

[127]  D. Dewitt,et al.  Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[128]  B. Kommerell,et al.  sn-1,2-Diacylglycerols and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human promyelocytic leukemia cells. , 1987, The Journal of clinical investigation.

[129]  W. Waddell,et al.  Sulindac for polyposis of the colon , 1983, Journal of surgical oncology.

[130]  B. Samuelsson.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.

[131]  T. Slaga,et al.  Indomethacin enhancement of TPA tumor promotion in mice. , 1980, Cancer letters.

[132]  J. Jacquemier,et al.  Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. , 1980, Journal of the National Cancer Institute.

[133]  P. L. Taylor,et al.  19-HydroxyIated E prostaglandins as the major prostaglandins of human semen , 1974, Nature.

[134]  J. Vane,et al.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.

[135]  F. Matschinsky,et al.  Prostaglandins: Enzymatic Analysis , 1969, Science.

[136]  M. Hamberg,et al.  Absolute Configuration of the Prostaglandins , 1966, Nature.

[137]  U. S. Euler.  An adrenaline-like action in extracts from the prostatic and related glands. , 1934 .

[138]  G. Burr,et al.  ON THE NATURE AND RÔLE OF THE FATTY ACIDS ESSENTIAL IN NUTRITION , 1930 .

[139]  L. Marnett,et al.  COX-2: a target for colon cancer prevention. , 2002, Annual review of pharmacology and toxicology.

[140]  J. Minna,et al.  Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[141]  Edgar M Moran,et al.  Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks. , 2002, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[142]  M. Maemondo,et al.  Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth. , 2002, Cancer research.

[143]  S. Narumiya,et al.  Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. , 2002, Cancer research.

[144]  R. Roberts,et al.  Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma. , 2001, Neoplasia.

[145]  C. Rüegg,et al.  NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. , 2001, Nature medicine.

[146]  R. Panettieri,et al.  p38 MAP kinase regulates IL-1 beta responses in cultured airway smooth muscle cells. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[147]  A. Knox,et al.  TGF-beta1 stimulates IL-8 release, COX-2 expression, and PGE(2) release in human airway smooth muscle cells. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[148]  D. Bostwick,et al.  Over‐expression of cyclooxygenase‐2 in human prostate adenocarcinoma , 2000, The Prostate.

[149]  K. Kinzler,et al.  PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. , 1999, Cell.

[150]  J. Lehmann,et al.  Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. , 1997, The Journal of biological chemistry.

[151]  R. DuBois,et al.  Colorectal cancer and nonsteroidal anti-inflammatory drugs. , 1997, Advances in pharmacology.

[152]  R. Kurumbail,et al.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1996, Nature.

[153]  G. Hunninghake,et al.  Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. , 1994, The Journal of clinical investigation.

[154]  D. Visscher,et al.  Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. , 1993, Analytical and quantitative cytology and histology.

[155]  F. Marks,et al.  Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion). , 1989, Carcinogenesis.

[156]  M. Caton.  The prostaglandins. , 1971, Progress in medicinal chemistry.